Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Ford Robert B
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Boudreau Philip P
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer MCCOY JOHN A. JR.
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Morrone Louis H.
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Abbott Laboratories | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Funck, Jr. Robert E.
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Earnhardt Lisa D
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director STARKS DANIEL J
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director O'Grady Michael
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director McKinstry Nancy
No Data
No Data